CTSO.US Cytosorbents Crp

Healthcare Health Care Equipment & Supplies USA Stocks
4.87 USD
Close of Nov 13, 2026
2.84 17.00
Market cap
USD 15.3M
P/E
-
P/B
11.43x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is CTSO.US undervalued?

Graham number

The Graham number of Cytosorbents Crp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cytosorbents Crp fundamental analysis

No fundamental analysis for Cytosorbents Crp yet.

Cytosorbents Crp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cytosorbents Crp

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and internationally. Its flagship product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses, bilirubin in liver failure, myoglobin in trauma and critical illnesses, and inflammatory mediators and blood thinners in cardiac surgery …

Full company profile